nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—ADRA2B—hypertension	0.0932	0.261	CbGaD
Apomorphine—HTR2B—hypertension	0.0769	0.216	CbGaD
Apomorphine—HTR1B—hypertension	0.0461	0.129	CbGaD
Apomorphine—DRD3—hypertension	0.0447	0.126	CbGaD
Apomorphine—ADRA2A—hypertension	0.0408	0.114	CbGaD
Apomorphine—DRD2—hypertension	0.031	0.0869	CbGaD
Apomorphine—HTR2A—hypertension	0.0239	0.0671	CbGaD
Apomorphine—DRD5—Fenoldopam—hypertension	0.0222	0.0554	CbGbCtD
Apomorphine—HTR1B—Pindolol—hypertension	0.0147	0.0366	CbGbCtD
Apomorphine—ADRA2C—Guanabenz—hypertension	0.0144	0.0358	CbGbCtD
Apomorphine—ADRA1D—Terazosin—hypertension	0.0138	0.0344	CbGbCtD
Apomorphine—ADRA2B—Guanabenz—hypertension	0.0136	0.0339	CbGbCtD
Apomorphine—ADRA2B—Guanfacine—hypertension	0.0127	0.0316	CbGbCtD
Apomorphine—ADRA1D—Fenoldopam—hypertension	0.0125	0.0312	CbGbCtD
Apomorphine—HTR1B—Penbutolol—hypertension	0.012	0.0299	CbGbCtD
Apomorphine—ADRA1D—Doxazosin—hypertension	0.0115	0.0288	CbGbCtD
Apomorphine—ADRA2C—Fenoldopam—hypertension	0.0114	0.0283	CbGbCtD
Apomorphine—DRD1—Fenoldopam—hypertension	0.0114	0.0283	CbGbCtD
Apomorphine—HTR1A—Nebivolol—hypertension	0.0108	0.027	CbGbCtD
Apomorphine—ADRA2B—Fenoldopam—hypertension	0.0108	0.0268	CbGbCtD
Apomorphine—ADRA2A—Methyldopa—hypertension	0.0104	0.0258	CbGbCtD
Apomorphine—ADRA1B—Terazosin—hypertension	0.0101	0.0251	CbGbCtD
Apomorphine—HTR1D—Prazosin—hypertension	0.00989	0.0246	CbGbCtD
Apomorphine—ADRA1D—Prazosin—hypertension	0.00948	0.0236	CbGbCtD
Apomorphine—ADRA2A—Guanabenz—hypertension	0.00948	0.0236	CbGbCtD
Apomorphine—HTR1A—Pindolol—hypertension	0.00922	0.0229	CbGbCtD
Apomorphine—ADRA1B—Fenoldopam—hypertension	0.00911	0.0227	CbGbCtD
Apomorphine—ADRA2A—Guanfacine—hypertension	0.00881	0.0219	CbGbCtD
Apomorphine—ADRA1B—Doxazosin—hypertension	0.0084	0.0209	CbGbCtD
Apomorphine—ADRA1D—Carvedilol—hypertension	0.00818	0.0204	CbGbCtD
Apomorphine—ADRA1D—Nicardipine—hypertension	0.00818	0.0204	CbGbCtD
Apomorphine—ADRA2B—Prazosin—hypertension	0.00817	0.0203	CbGbCtD
Apomorphine—HTR1B—Propranolol—hypertension	0.00753	0.0188	CbGbCtD
Apomorphine—HTR1A—Penbutolol—hypertension	0.00751	0.0187	CbGbCtD
Apomorphine—ADRA2A—Fenoldopam—hypertension	0.00749	0.0187	CbGbCtD
Apomorphine—ADRA2C—Carvedilol—hypertension	0.00743	0.0185	CbGbCtD
Apomorphine—ADRA1D—Clonidine—hypertension	0.00719	0.0179	CbGbCtD
Apomorphine—ADRA2B—Carvedilol—hypertension	0.00705	0.0176	CbGbCtD
Apomorphine—ADRA2A—Doxazosin—hypertension	0.00692	0.0172	CbGbCtD
Apomorphine—DRD2—Fenoldopam—hypertension	0.0069	0.0172	CbGbCtD
Apomorphine—ADRA1B—Prazosin—hypertension	0.0069	0.0172	CbGbCtD
Apomorphine—ADRA2C—Clonidine—hypertension	0.00652	0.0162	CbGbCtD
Apomorphine—ADRA2B—Clonidine—hypertension	0.00619	0.0154	CbGbCtD
Apomorphine—ADRA1B—Nicardipine—hypertension	0.00596	0.0148	CbGbCtD
Apomorphine—ADRA1B—Carvedilol—hypertension	0.00596	0.0148	CbGbCtD
Apomorphine—HTR1A—Prazosin—hypertension	0.00594	0.0148	CbGbCtD
Apomorphine—ADRA2A—Prazosin—hypertension	0.00568	0.0141	CbGbCtD
Apomorphine—ADRA1B—vas deferens—hypertension	0.00535	0.177	CbGeAlD
Apomorphine—ADRA1B—Clonidine—hypertension	0.00523	0.013	CbGbCtD
Apomorphine—ADRA2A—Carvedilol—hypertension	0.0049	0.0122	CbGbCtD
Apomorphine—HTR1A—Propranolol—hypertension	0.00472	0.0117	CbGbCtD
Apomorphine—ADRA2A—Clonidine—hypertension	0.0043	0.0107	CbGbCtD
Apomorphine—HTR2A—arteriole—hypertension	0.00138	0.0458	CbGeAlD
Apomorphine—HTR2A—locus ceruleus—hypertension	0.00112	0.0369	CbGeAlD
Apomorphine—HTR2A—pulmonary artery—hypertension	0.000906	0.03	CbGeAlD
Apomorphine—HTR2A—sympathetic nervous system—hypertension	0.000881	0.0292	CbGeAlD
Apomorphine—HTR2A—vagus nerve—hypertension	0.000854	0.0282	CbGeAlD
Apomorphine—HTR2A—vein—hypertension	0.000825	0.0273	CbGeAlD
Apomorphine—HTR1B—artery—hypertension	0.000699	0.0231	CbGeAlD
Apomorphine—HTR1D—artery—hypertension	0.000676	0.0224	CbGeAlD
Apomorphine—CALY—medulla oblongata—hypertension	0.000662	0.0219	CbGeAlD
Apomorphine—DRD4—heart—hypertension	0.000631	0.0209	CbGeAlD
Apomorphine—HTR2A—autonomic nervous system—hypertension	0.000593	0.0196	CbGeAlD
Apomorphine—HTR2A—hindlimb—hypertension	0.000548	0.0181	CbGeAlD
Apomorphine—HTR1B—blood vessel—hypertension	0.000544	0.018	CbGeAlD
Apomorphine—CALY—endocrine gland—hypertension	0.000532	0.0176	CbGeAlD
Apomorphine—HTR1D—blood vessel—hypertension	0.000527	0.0174	CbGeAlD
Apomorphine—HTR2A—urine—hypertension	0.000483	0.016	CbGeAlD
Apomorphine—CALY—central nervous system—hypertension	0.000479	0.0158	CbGeAlD
Apomorphine—DRD1—brainstem—hypertension	0.000367	0.0121	CbGeAlD
Apomorphine—HTR2A—artery—hypertension	0.000336	0.0111	CbGeAlD
Apomorphine—ADRA1B—kidney—hypertension	0.000315	0.0104	CbGeAlD
Apomorphine—HTR1B—brainstem—hypertension	0.000297	0.00984	CbGeAlD
Apomorphine—HTR1D—brainstem—hypertension	0.000288	0.00953	CbGeAlD
Apomorphine—HTR2C—brainstem—hypertension	0.000285	0.00944	CbGeAlD
Apomorphine—HTR2A—endothelium—hypertension	0.000284	0.00939	CbGeAlD
Apomorphine—ADRA2C—cardiac ventricle—hypertension	0.000278	0.00919	CbGeAlD
Apomorphine—DRD5—endocrine gland—hypertension	0.000269	0.0089	CbGeAlD
Apomorphine—HTR2A—blood vessel—hypertension	0.000262	0.00866	CbGeAlD
Apomorphine—ADRA2C—myocardium—hypertension	0.000261	0.00865	CbGeAlD
Apomorphine—DRD3—central nervous system—hypertension	0.000259	0.00856	CbGeAlD
Apomorphine—HTR1B—cardiovascular system—hypertension	0.000243	0.00803	CbGeAlD
Apomorphine—DRD5—central nervous system—hypertension	0.000242	0.00802	CbGeAlD
Apomorphine—HTR1A—brainstem—hypertension	0.00024	0.00794	CbGeAlD
Apomorphine—HTR2B—adrenal cortex—hypertension	0.00024	0.00793	CbGeAlD
Apomorphine—HTR1D—cardiovascular system—hypertension	0.000235	0.00778	CbGeAlD
Apomorphine—HTR2B—heart—hypertension	0.000232	0.00767	CbGeAlD
Apomorphine—HTR1D—kidney—hypertension	0.00023	0.00761	CbGeAlD
Apomorphine—HTR2B—smooth muscle tissue—hypertension	0.00023	0.00761	CbGeAlD
Apomorphine—HTR2B—decidua—hypertension	0.000225	0.00746	CbGeAlD
Apomorphine—HTR2B—cardiovascular system—hypertension	0.000219	0.00724	CbGeAlD
Apomorphine—DRD2—brainstem—hypertension	0.000217	0.00718	CbGeAlD
Apomorphine—ADRA1D—endocrine gland—hypertension	0.000216	0.00714	CbGeAlD
Apomorphine—HTR2B—cortex of kidney—hypertension	0.000208	0.00689	CbGeAlD
Apomorphine—HTR2C—medulla oblongata—hypertension	0.000199	0.00658	CbGeAlD
Apomorphine—ADRA1B—central nervous system—hypertension	0.000199	0.00657	CbGeAlD
Apomorphine—HTR1A—cardiovascular system—hypertension	0.000196	0.00648	CbGeAlD
Apomorphine—ADRA1D—central nervous system—hypertension	0.000194	0.00643	CbGeAlD
Apomorphine—ADRA2C—nephron tubule—hypertension	0.000192	0.00634	CbGeAlD
Apomorphine—ADRA2C—adrenal cortex—hypertension	0.000189	0.00624	CbGeAlD
Apomorphine—DRD1—central nervous system—hypertension	0.000185	0.00613	CbGeAlD
Apomorphine—ADRA2C—heart—hypertension	0.000182	0.00603	CbGeAlD
Apomorphine—ADRA2C—decidua—hypertension	0.000177	0.00587	CbGeAlD
Apomorphine—HTR2B—adrenal gland—hypertension	0.000173	0.00572	CbGeAlD
Apomorphine—ADRA2C—kidney—hypertension	0.000168	0.00557	CbGeAlD
Apomorphine—HTR1B—endocrine gland—hypertension	0.000167	0.00551	CbGeAlD
Apomorphine—ADRA2C—cortex of kidney—hypertension	0.000164	0.00543	CbGeAlD
Apomorphine—ADRA2C—cardiac atrium—hypertension	0.000156	0.00516	CbGeAlD
Apomorphine—HTR1A—adrenal gland—hypertension	0.000155	0.00513	CbGeAlD
Apomorphine—HTR1B—central nervous system—hypertension	0.00015	0.00497	CbGeAlD
Apomorphine—ADRA2C—medulla oblongata—hypertension	0.000147	0.00487	CbGeAlD
Apomorphine—ADRA2A—heart—hypertension	0.000146	0.00482	CbGeAlD
Apomorphine—HTR1D—central nervous system—hypertension	0.000145	0.00481	CbGeAlD
Apomorphine—HTR2C—central nervous system—hypertension	0.000144	0.00476	CbGeAlD
Apomorphine—HTR2A—brainstem—hypertension	0.000143	0.00473	CbGeAlD
Apomorphine—ADRA2A—decidua—hypertension	0.000142	0.00468	CbGeAlD
Apomorphine—ADRA2C—adrenal gland—hypertension	0.000136	0.0045	CbGeAlD
Apomorphine—HTR2B—central nervous system—hypertension	0.000135	0.00447	CbGeAlD
Apomorphine—HTR1A—endocrine gland—hypertension	0.000134	0.00445	CbGeAlD
Apomorphine—ADRA2A—cortex of kidney—hypertension	0.000131	0.00433	CbGeAlD
Apomorphine—ADRA2A—cardiac atrium—hypertension	0.000124	0.00412	CbGeAlD
Apomorphine—HTR2A—heart—hypertension	0.000124	0.00409	CbGeAlD
Apomorphine—HTR2A—smooth muscle tissue—hypertension	0.000123	0.00406	CbGeAlD
Apomorphine—DRD2—endocrine gland—hypertension	0.000121	0.00402	CbGeAlD
Apomorphine—HTR1A—central nervous system—hypertension	0.000121	0.00401	CbGeAlD
Apomorphine—ADRA2A—medulla oblongata—hypertension	0.000117	0.00388	CbGeAlD
Apomorphine—HTR2A—cardiovascular system—hypertension	0.000117	0.00386	CbGeAlD
Apomorphine—HTR2A—kidney—hypertension	0.000114	0.00378	CbGeAlD
Apomorphine—DRD2—central nervous system—hypertension	0.000109	0.00362	CbGeAlD
Apomorphine—ADRA2A—adrenal gland—hypertension	0.000109	0.00359	CbGeAlD
Apomorphine—ADRA2C—central nervous system—hypertension	0.000106	0.00352	CbGeAlD
Apomorphine—HTR2A—medulla oblongata—hypertension	9.98e-05	0.0033	CbGeAlD
Apomorphine—ADRA2A—endocrine gland—hypertension	9.42e-05	0.00312	CbGeAlD
Apomorphine—HTR2A—adrenal gland—hypertension	9.24e-05	0.00306	CbGeAlD
Apomorphine—ADRA2A—central nervous system—hypertension	8.49e-05	0.00281	CbGeAlD
Apomorphine—HTR2A—endocrine gland—hypertension	8.01e-05	0.00265	CbGeAlD
Apomorphine—HTR2A—central nervous system—hypertension	7.22e-05	0.00239	CbGeAlD
Apomorphine—Dizziness—Propranolol—hypertension	4.03e-05	0.000349	CcSEcCtD
Apomorphine—Insomnia—Hydrochlorothiazide—hypertension	4.02e-05	0.000349	CcSEcCtD
Apomorphine—Asthenia—Verapamil—hypertension	4.02e-05	0.000349	CcSEcCtD
Apomorphine—Pruritus—Eplerenone—hypertension	4.01e-05	0.000348	CcSEcCtD
Apomorphine—Dyspnoea—Perindopril—hypertension	4.01e-05	0.000348	CcSEcCtD
Apomorphine—Somnolence—Perindopril—hypertension	4e-05	0.000347	CcSEcCtD
Apomorphine—Dyspnoea—Irbesartan—hypertension	4e-05	0.000347	CcSEcCtD
Apomorphine—Feeling abnormal—Trandolapril—hypertension	4e-05	0.000347	CcSEcCtD
Apomorphine—Diarrhoea—Carvedilol—hypertension	4e-05	0.000346	CcSEcCtD
Apomorphine—Fatigue—Captopril—hypertension	4e-05	0.000346	CcSEcCtD
Apomorphine—Somnolence—Irbesartan—hypertension	3.99e-05	0.000346	CcSEcCtD
Apomorphine—Pruritus—Nifedipine—hypertension	3.98e-05	0.000345	CcSEcCtD
Apomorphine—Feeling abnormal—Enalapril—hypertension	3.98e-05	0.000345	CcSEcCtD
Apomorphine—Syncope—Ramipril—hypertension	3.98e-05	0.000345	CcSEcCtD
Apomorphine—Pruritus—Verapamil—hypertension	3.97e-05	0.000344	CcSEcCtD
Apomorphine—Dyspnoea—Hydrochlorothiazide—hypertension	3.97e-05	0.000344	CcSEcCtD
Apomorphine—Constipation—Captopril—hypertension	3.96e-05	0.000344	CcSEcCtD
Apomorphine—Somnolence—Hydrochlorothiazide—hypertension	3.96e-05	0.000343	CcSEcCtD
Apomorphine—Diarrhoea—Doxazosin—hypertension	3.95e-05	0.000343	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Betaxolol—hypertension	3.95e-05	0.000342	CcSEcCtD
Apomorphine—Hypotension—Losartan—hypertension	3.95e-05	0.000342	CcSEcCtD
Apomorphine—Nausea—Guanabenz—hypertension	3.94e-05	0.000342	CcSEcCtD
Apomorphine—Nausea—Metoprolol—hypertension	3.94e-05	0.000342	CcSEcCtD
Apomorphine—Feeling abnormal—Telmisartan—hypertension	3.93e-05	0.00034	CcSEcCtD
Apomorphine—Insomnia—Betaxolol—hypertension	3.92e-05	0.00034	CcSEcCtD
Apomorphine—Diarrhoea—Fosinopril—hypertension	3.91e-05	0.000338	CcSEcCtD
Apomorphine—Dizziness—Diltiazem—hypertension	3.9e-05	0.000338	CcSEcCtD
Apomorphine—Dizziness—Indapamide—hypertension	3.9e-05	0.000338	CcSEcCtD
Apomorphine—Loss of consciousness—Ramipril—hypertension	3.9e-05	0.000338	CcSEcCtD
Apomorphine—Back pain—Lisinopril—hypertension	3.89e-05	0.000337	CcSEcCtD
Apomorphine—Somnolence—Furosemide—hypertension	3.89e-05	0.000337	CcSEcCtD
Apomorphine—Syncope—Timolol—hypertension	3.89e-05	0.000337	CcSEcCtD
Apomorphine—Diarrhoea—Eplerenone—hypertension	3.88e-05	0.000336	CcSEcCtD
Apomorphine—Fatigue—Perindopril—hypertension	3.88e-05	0.000336	CcSEcCtD
Apomorphine—Vomiting—Propranolol—hypertension	3.88e-05	0.000336	CcSEcCtD
Apomorphine—Fatigue—Irbesartan—hypertension	3.87e-05	0.000335	CcSEcCtD
Apomorphine—Dizziness—Carvedilol—hypertension	3.86e-05	0.000335	CcSEcCtD
Apomorphine—Dyspnoea—Betaxolol—hypertension	3.86e-05	0.000335	CcSEcCtD
Apomorphine—Diarrhoea—Nifedipine—hypertension	3.85e-05	0.000334	CcSEcCtD
Apomorphine—Constipation—Perindopril—hypertension	3.85e-05	0.000334	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Losartan—hypertension	3.85e-05	0.000333	CcSEcCtD
Apomorphine—Diarrhoea—Verapamil—hypertension	3.84e-05	0.000332	CcSEcCtD
Apomorphine—Constipation—Irbesartan—hypertension	3.84e-05	0.000332	CcSEcCtD
Apomorphine—Fatigue—Hydrochlorothiazide—hypertension	3.84e-05	0.000332	CcSEcCtD
Apomorphine—Dizziness—Doxazosin—hypertension	3.82e-05	0.000331	CcSEcCtD
Apomorphine—Feeling abnormal—Captopril—hypertension	3.82e-05	0.000331	CcSEcCtD
Apomorphine—Insomnia—Losartan—hypertension	3.82e-05	0.000331	CcSEcCtD
Apomorphine—Loss of consciousness—Timolol—hypertension	3.81e-05	0.00033	CcSEcCtD
Apomorphine—Constipation—Hydrochlorothiazide—hypertension	3.8e-05	0.00033	CcSEcCtD
Apomorphine—Chest pain—Ramipril—hypertension	3.78e-05	0.000327	CcSEcCtD
Apomorphine—Arthralgia—Ramipril—hypertension	3.78e-05	0.000327	CcSEcCtD
Apomorphine—Dizziness—Fosinopril—hypertension	3.77e-05	0.000327	CcSEcCtD
Apomorphine—Fatigue—Furosemide—hypertension	3.77e-05	0.000327	CcSEcCtD
Apomorphine—Dyspnoea—Losartan—hypertension	3.76e-05	0.000326	CcSEcCtD
Apomorphine—Anxiety—Ramipril—hypertension	3.76e-05	0.000326	CcSEcCtD
Apomorphine—Somnolence—Losartan—hypertension	3.75e-05	0.000325	CcSEcCtD
Apomorphine—Dizziness—Eplerenone—hypertension	3.75e-05	0.000325	CcSEcCtD
Apomorphine—Vomiting—Indapamide—hypertension	3.75e-05	0.000325	CcSEcCtD
Apomorphine—Vomiting—Diltiazem—hypertension	3.75e-05	0.000325	CcSEcCtD
Apomorphine—Asthenia—Valsartan—hypertension	3.75e-05	0.000325	CcSEcCtD
Apomorphine—Constipation—Furosemide—hypertension	3.74e-05	0.000324	CcSEcCtD
Apomorphine—Fatigue—Betaxolol—hypertension	3.73e-05	0.000324	CcSEcCtD
Apomorphine—Asthenia—Olmesartan—hypertension	3.73e-05	0.000323	CcSEcCtD
Apomorphine—Dizziness—Nifedipine—hypertension	3.72e-05	0.000323	CcSEcCtD
Apomorphine—Vomiting—Carvedilol—hypertension	3.71e-05	0.000322	CcSEcCtD
Apomorphine—Feeling abnormal—Perindopril—hypertension	3.71e-05	0.000321	CcSEcCtD
Apomorphine—Dizziness—Verapamil—hypertension	3.71e-05	0.000321	CcSEcCtD
Apomorphine—Constipation—Betaxolol—hypertension	3.7e-05	0.000321	CcSEcCtD
Apomorphine—Feeling abnormal—Irbesartan—hypertension	3.7e-05	0.00032	CcSEcCtD
Apomorphine—Headache—Indapamide—hypertension	3.7e-05	0.00032	CcSEcCtD
Apomorphine—Headache—Diltiazem—hypertension	3.7e-05	0.00032	CcSEcCtD
Apomorphine—Pruritus—Valsartan—hypertension	3.69e-05	0.00032	CcSEcCtD
Apomorphine—Arthralgia—Timolol—hypertension	3.69e-05	0.00032	CcSEcCtD
Apomorphine—Chest pain—Timolol—hypertension	3.69e-05	0.00032	CcSEcCtD
Apomorphine—Anxiety—Timolol—hypertension	3.68e-05	0.000319	CcSEcCtD
Apomorphine—Pruritus—Olmesartan—hypertension	3.68e-05	0.000318	CcSEcCtD
Apomorphine—Vomiting—Doxazosin—hypertension	3.67e-05	0.000318	CcSEcCtD
Apomorphine—Feeling abnormal—Hydrochlorothiazide—hypertension	3.67e-05	0.000318	CcSEcCtD
Apomorphine—Headache—Carvedilol—hypertension	3.66e-05	0.000317	CcSEcCtD
Apomorphine—Confusional state—Ramipril—hypertension	3.65e-05	0.000316	CcSEcCtD
Apomorphine—Fatigue—Losartan—hypertension	3.64e-05	0.000315	CcSEcCtD
Apomorphine—Vomiting—Fosinopril—hypertension	3.63e-05	0.000314	CcSEcCtD
Apomorphine—Nausea—Propranolol—hypertension	3.62e-05	0.000314	CcSEcCtD
Apomorphine—Oedema—Ramipril—hypertension	3.62e-05	0.000314	CcSEcCtD
Apomorphine—Headache—Doxazosin—hypertension	3.62e-05	0.000314	CcSEcCtD
Apomorphine—Constipation—Losartan—hypertension	3.61e-05	0.000313	CcSEcCtD
Apomorphine—Syncope—Lisinopril—hypertension	3.61e-05	0.000313	CcSEcCtD
Apomorphine—Vomiting—Eplerenone—hypertension	3.61e-05	0.000313	CcSEcCtD
Apomorphine—Feeling abnormal—Furosemide—hypertension	3.61e-05	0.000312	CcSEcCtD
Apomorphine—Vomiting—Nifedipine—hypertension	3.58e-05	0.00031	CcSEcCtD
Apomorphine—Headache—Fosinopril—hypertension	3.58e-05	0.00031	CcSEcCtD
Apomorphine—Diarrhoea—Valsartan—hypertension	3.57e-05	0.000309	CcSEcCtD
Apomorphine—Asthenia—Clonidine—hypertension	3.57e-05	0.000309	CcSEcCtD
Apomorphine—Feeling abnormal—Betaxolol—hypertension	3.57e-05	0.000309	CcSEcCtD
Apomorphine—Confusional state—Timolol—hypertension	3.57e-05	0.000309	CcSEcCtD
Apomorphine—Vomiting—Verapamil—hypertension	3.57e-05	0.000309	CcSEcCtD
Apomorphine—Shock—Ramipril—hypertension	3.56e-05	0.000309	CcSEcCtD
Apomorphine—Diarrhoea—Olmesartan—hypertension	3.55e-05	0.000308	CcSEcCtD
Apomorphine—Headache—Eplerenone—hypertension	3.55e-05	0.000308	CcSEcCtD
Apomorphine—Oedema—Timolol—hypertension	3.54e-05	0.000307	CcSEcCtD
Apomorphine—Loss of consciousness—Lisinopril—hypertension	3.54e-05	0.000306	CcSEcCtD
Apomorphine—Headache—Nifedipine—hypertension	3.53e-05	0.000306	CcSEcCtD
Apomorphine—Pruritus—Clonidine—hypertension	3.52e-05	0.000305	CcSEcCtD
Apomorphine—Headache—Verapamil—hypertension	3.51e-05	0.000304	CcSEcCtD
Apomorphine—Nausea—Diltiazem—hypertension	3.5e-05	0.000304	CcSEcCtD
Apomorphine—Nausea—Indapamide—hypertension	3.5e-05	0.000304	CcSEcCtD
Apomorphine—Hyperhidrosis—Ramipril—hypertension	3.5e-05	0.000303	CcSEcCtD
Apomorphine—Asthenia—Trandolapril—hypertension	3.48e-05	0.000302	CcSEcCtD
Apomorphine—Shock—Timolol—hypertension	3.48e-05	0.000302	CcSEcCtD
Apomorphine—Feeling abnormal—Losartan—hypertension	3.48e-05	0.000301	CcSEcCtD
Apomorphine—Nausea—Carvedilol—hypertension	3.47e-05	0.000301	CcSEcCtD
Apomorphine—Asthenia—Enalapril—hypertension	3.47e-05	0.0003	CcSEcCtD
Apomorphine—Dizziness—Valsartan—hypertension	3.45e-05	0.000299	CcSEcCtD
Apomorphine—Dizziness—Olmesartan—hypertension	3.44e-05	0.000298	CcSEcCtD
Apomorphine—Pruritus—Trandolapril—hypertension	3.43e-05	0.000298	CcSEcCtD
Apomorphine—Nausea—Doxazosin—hypertension	3.43e-05	0.000297	CcSEcCtD
Apomorphine—Chest pain—Lisinopril—hypertension	3.42e-05	0.000297	CcSEcCtD
Apomorphine—Arthralgia—Lisinopril—hypertension	3.42e-05	0.000297	CcSEcCtD
Apomorphine—Hyperhidrosis—Timolol—hypertension	3.42e-05	0.000296	CcSEcCtD
Apomorphine—Asthenia—Telmisartan—hypertension	3.42e-05	0.000296	CcSEcCtD
Apomorphine—Pruritus—Enalapril—hypertension	3.42e-05	0.000296	CcSEcCtD
Apomorphine—Anxiety—Lisinopril—hypertension	3.41e-05	0.000296	CcSEcCtD
Apomorphine—Diarrhoea—Clonidine—hypertension	3.4e-05	0.000295	CcSEcCtD
Apomorphine—Nausea—Fosinopril—hypertension	3.39e-05	0.000294	CcSEcCtD
Apomorphine—Hypotension—Ramipril—hypertension	3.38e-05	0.000293	CcSEcCtD
Apomorphine—Pruritus—Telmisartan—hypertension	3.37e-05	0.000292	CcSEcCtD
Apomorphine—Nausea—Eplerenone—hypertension	3.37e-05	0.000292	CcSEcCtD
Apomorphine—Nausea—Nifedipine—hypertension	3.35e-05	0.00029	CcSEcCtD
Apomorphine—Nausea—Verapamil—hypertension	3.33e-05	0.000289	CcSEcCtD
Apomorphine—Asthenia—Captopril—hypertension	3.33e-05	0.000288	CcSEcCtD
Apomorphine—Diarrhoea—Trandolapril—hypertension	3.32e-05	0.000288	CcSEcCtD
Apomorphine—Vomiting—Valsartan—hypertension	3.32e-05	0.000288	CcSEcCtD
Apomorphine—Confusional state—Lisinopril—hypertension	3.31e-05	0.000287	CcSEcCtD
Apomorphine—Diarrhoea—Enalapril—hypertension	3.31e-05	0.000287	CcSEcCtD
Apomorphine—Hypotension—Timolol—hypertension	3.31e-05	0.000287	CcSEcCtD
Apomorphine—Vomiting—Olmesartan—hypertension	3.3e-05	0.000286	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Ramipril—hypertension	3.3e-05	0.000286	CcSEcCtD
Apomorphine—Dizziness—Clonidine—hypertension	3.29e-05	0.000285	CcSEcCtD
Apomorphine—Oedema—Lisinopril—hypertension	3.28e-05	0.000284	CcSEcCtD
Apomorphine—Pruritus—Captopril—hypertension	3.28e-05	0.000284	CcSEcCtD
Apomorphine—Insomnia—Ramipril—hypertension	3.27e-05	0.000284	CcSEcCtD
Apomorphine—Headache—Valsartan—hypertension	3.27e-05	0.000283	CcSEcCtD
Apomorphine—Diarrhoea—Telmisartan—hypertension	3.26e-05	0.000283	CcSEcCtD
Apomorphine—Headache—Olmesartan—hypertension	3.25e-05	0.000282	CcSEcCtD
Apomorphine—Shock—Lisinopril—hypertension	3.23e-05	0.00028	CcSEcCtD
Apomorphine—Asthenia—Perindopril—hypertension	3.23e-05	0.00028	CcSEcCtD
Apomorphine—Dyspnoea—Ramipril—hypertension	3.23e-05	0.00028	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Timolol—hypertension	3.22e-05	0.000279	CcSEcCtD
Apomorphine—Asthenia—Irbesartan—hypertension	3.22e-05	0.000279	CcSEcCtD
Apomorphine—Somnolence—Ramipril—hypertension	3.22e-05	0.000279	CcSEcCtD
Apomorphine—Dizziness—Trandolapril—hypertension	3.21e-05	0.000278	CcSEcCtD
Apomorphine—Insomnia—Timolol—hypertension	3.2e-05	0.000277	CcSEcCtD
Apomorphine—Dizziness—Enalapril—hypertension	3.2e-05	0.000277	CcSEcCtD
Apomorphine—Asthenia—Hydrochlorothiazide—hypertension	3.19e-05	0.000277	CcSEcCtD
Apomorphine—Pruritus—Perindopril—hypertension	3.18e-05	0.000276	CcSEcCtD
Apomorphine—Pruritus—Irbesartan—hypertension	3.17e-05	0.000275	CcSEcCtD
Apomorphine—Hyperhidrosis—Lisinopril—hypertension	3.17e-05	0.000275	CcSEcCtD
Apomorphine—Diarrhoea—Captopril—hypertension	3.17e-05	0.000275	CcSEcCtD
Apomorphine—Vomiting—Clonidine—hypertension	3.16e-05	0.000274	CcSEcCtD
Apomorphine—Dyspnoea—Timolol—hypertension	3.16e-05	0.000273	CcSEcCtD
Apomorphine—Dizziness—Telmisartan—hypertension	3.15e-05	0.000273	CcSEcCtD
Apomorphine—Pruritus—Hydrochlorothiazide—hypertension	3.15e-05	0.000273	CcSEcCtD
Apomorphine—Somnolence—Timolol—hypertension	3.15e-05	0.000273	CcSEcCtD
Apomorphine—Asthenia—Furosemide—hypertension	3.14e-05	0.000272	CcSEcCtD
Apomorphine—Fatigue—Ramipril—hypertension	3.12e-05	0.00027	CcSEcCtD
Apomorphine—Headache—Clonidine—hypertension	3.12e-05	0.00027	CcSEcCtD
Apomorphine—Asthenia—Betaxolol—hypertension	3.11e-05	0.000269	CcSEcCtD
Apomorphine—Nausea—Valsartan—hypertension	3.1e-05	0.000269	CcSEcCtD
Apomorphine—Pruritus—Furosemide—hypertension	3.1e-05	0.000268	CcSEcCtD
Apomorphine—Constipation—Ramipril—hypertension	3.1e-05	0.000268	CcSEcCtD
Apomorphine—Nausea—Olmesartan—hypertension	3.09e-05	0.000267	CcSEcCtD
Apomorphine—Vomiting—Trandolapril—hypertension	3.09e-05	0.000267	CcSEcCtD
Apomorphine—Diarrhoea—Perindopril—hypertension	3.08e-05	0.000267	CcSEcCtD
Apomorphine—Vomiting—Enalapril—hypertension	3.07e-05	0.000266	CcSEcCtD
Apomorphine—Diarrhoea—Irbesartan—hypertension	3.07e-05	0.000266	CcSEcCtD
Apomorphine—Hypotension—Lisinopril—hypertension	3.07e-05	0.000266	CcSEcCtD
Apomorphine—Dizziness—Captopril—hypertension	3.07e-05	0.000266	CcSEcCtD
Apomorphine—Pruritus—Betaxolol—hypertension	3.06e-05	0.000266	CcSEcCtD
Apomorphine—Fatigue—Timolol—hypertension	3.05e-05	0.000264	CcSEcCtD
Apomorphine—Diarrhoea—Hydrochlorothiazide—hypertension	3.04e-05	0.000264	CcSEcCtD
Apomorphine—Headache—Trandolapril—hypertension	3.04e-05	0.000263	CcSEcCtD
Apomorphine—Vomiting—Telmisartan—hypertension	3.03e-05	0.000263	CcSEcCtD
Apomorphine—Asthenia—Losartan—hypertension	3.03e-05	0.000262	CcSEcCtD
Apomorphine—Headache—Enalapril—hypertension	3.03e-05	0.000262	CcSEcCtD
Apomorphine—Diarrhoea—Furosemide—hypertension	2.99e-05	0.000259	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Lisinopril—hypertension	2.99e-05	0.000259	CcSEcCtD
Apomorphine—Pruritus—Losartan—hypertension	2.99e-05	0.000259	CcSEcCtD
Apomorphine—Headache—Telmisartan—hypertension	2.99e-05	0.000259	CcSEcCtD
Apomorphine—Feeling abnormal—Ramipril—hypertension	2.98e-05	0.000258	CcSEcCtD
Apomorphine—Dizziness—Perindopril—hypertension	2.98e-05	0.000258	CcSEcCtD
Apomorphine—Insomnia—Lisinopril—hypertension	2.97e-05	0.000257	CcSEcCtD
Apomorphine—Dizziness—Irbesartan—hypertension	2.97e-05	0.000257	CcSEcCtD
Apomorphine—Diarrhoea—Betaxolol—hypertension	2.96e-05	0.000257	CcSEcCtD
Apomorphine—Nausea—Clonidine—hypertension	2.96e-05	0.000256	CcSEcCtD
Apomorphine—Vomiting—Captopril—hypertension	2.95e-05	0.000255	CcSEcCtD
Apomorphine—Dizziness—Hydrochlorothiazide—hypertension	2.94e-05	0.000255	CcSEcCtD
Apomorphine—Dyspnoea—Lisinopril—hypertension	2.93e-05	0.000254	CcSEcCtD
Apomorphine—Somnolence—Lisinopril—hypertension	2.92e-05	0.000253	CcSEcCtD
Apomorphine—Feeling abnormal—Timolol—hypertension	2.92e-05	0.000253	CcSEcCtD
Apomorphine—Headache—Captopril—hypertension	2.9e-05	0.000252	CcSEcCtD
Apomorphine—Dizziness—Furosemide—hypertension	2.89e-05	0.000251	CcSEcCtD
Apomorphine—Diarrhoea—Losartan—hypertension	2.89e-05	0.00025	CcSEcCtD
Apomorphine—Nausea—Trandolapril—hypertension	2.88e-05	0.00025	CcSEcCtD
Apomorphine—Nausea—Enalapril—hypertension	2.87e-05	0.000249	CcSEcCtD
Apomorphine—Dizziness—Betaxolol—hypertension	2.86e-05	0.000248	CcSEcCtD
Apomorphine—Vomiting—Perindopril—hypertension	2.86e-05	0.000248	CcSEcCtD
Apomorphine—Vomiting—Irbesartan—hypertension	2.85e-05	0.000247	CcSEcCtD
Apomorphine—Nausea—Telmisartan—hypertension	2.83e-05	0.000245	CcSEcCtD
Apomorphine—Fatigue—Lisinopril—hypertension	2.83e-05	0.000245	CcSEcCtD
Apomorphine—Vomiting—Hydrochlorothiazide—hypertension	2.83e-05	0.000245	CcSEcCtD
Apomorphine—Headache—Perindopril—hypertension	2.82e-05	0.000244	CcSEcCtD
Apomorphine—Headache—Irbesartan—hypertension	2.81e-05	0.000244	CcSEcCtD
Apomorphine—Constipation—Lisinopril—hypertension	2.81e-05	0.000243	CcSEcCtD
Apomorphine—Dizziness—Losartan—hypertension	2.79e-05	0.000242	CcSEcCtD
Apomorphine—Headache—Hydrochlorothiazide—hypertension	2.79e-05	0.000242	CcSEcCtD
Apomorphine—Vomiting—Furosemide—hypertension	2.78e-05	0.000241	CcSEcCtD
Apomorphine—Vomiting—Betaxolol—hypertension	2.75e-05	0.000239	CcSEcCtD
Apomorphine—Nausea—Captopril—hypertension	2.75e-05	0.000239	CcSEcCtD
Apomorphine—Headache—Furosemide—hypertension	2.74e-05	0.000238	CcSEcCtD
Apomorphine—Headache—Betaxolol—hypertension	2.71e-05	0.000235	CcSEcCtD
Apomorphine—Feeling abnormal—Lisinopril—hypertension	2.71e-05	0.000234	CcSEcCtD
Apomorphine—Vomiting—Losartan—hypertension	2.68e-05	0.000233	CcSEcCtD
Apomorphine—Nausea—Perindopril—hypertension	2.67e-05	0.000232	CcSEcCtD
Apomorphine—Nausea—Irbesartan—hypertension	2.66e-05	0.000231	CcSEcCtD
Apomorphine—Headache—Losartan—hypertension	2.64e-05	0.000229	CcSEcCtD
Apomorphine—Nausea—Hydrochlorothiazide—hypertension	2.64e-05	0.000229	CcSEcCtD
Apomorphine—Nausea—Furosemide—hypertension	2.6e-05	0.000225	CcSEcCtD
Apomorphine—Asthenia—Ramipril—hypertension	2.6e-05	0.000225	CcSEcCtD
Apomorphine—Nausea—Betaxolol—hypertension	2.57e-05	0.000223	CcSEcCtD
Apomorphine—Pruritus—Ramipril—hypertension	2.56e-05	0.000222	CcSEcCtD
Apomorphine—Asthenia—Timolol—hypertension	2.54e-05	0.00022	CcSEcCtD
Apomorphine—Nausea—Losartan—hypertension	2.51e-05	0.000217	CcSEcCtD
Apomorphine—Pruritus—Timolol—hypertension	2.5e-05	0.000217	CcSEcCtD
Apomorphine—Diarrhoea—Ramipril—hypertension	2.48e-05	0.000215	CcSEcCtD
Apomorphine—Diarrhoea—Timolol—hypertension	2.42e-05	0.00021	CcSEcCtD
Apomorphine—Dizziness—Ramipril—hypertension	2.39e-05	0.000207	CcSEcCtD
Apomorphine—Asthenia—Lisinopril—hypertension	2.36e-05	0.000204	CcSEcCtD
Apomorphine—Dizziness—Timolol—hypertension	2.34e-05	0.000203	CcSEcCtD
Apomorphine—Pruritus—Lisinopril—hypertension	2.32e-05	0.000201	CcSEcCtD
Apomorphine—Vomiting—Ramipril—hypertension	2.3e-05	0.000199	CcSEcCtD
Apomorphine—Headache—Ramipril—hypertension	2.27e-05	0.000197	CcSEcCtD
Apomorphine—Vomiting—Timolol—hypertension	2.25e-05	0.000195	CcSEcCtD
Apomorphine—Diarrhoea—Lisinopril—hypertension	2.25e-05	0.000195	CcSEcCtD
Apomorphine—Headache—Timolol—hypertension	2.22e-05	0.000192	CcSEcCtD
Apomorphine—Dizziness—Lisinopril—hypertension	2.17e-05	0.000188	CcSEcCtD
Apomorphine—Nausea—Ramipril—hypertension	2.15e-05	0.000186	CcSEcCtD
Apomorphine—Nausea—Timolol—hypertension	2.1e-05	0.000182	CcSEcCtD
Apomorphine—Vomiting—Lisinopril—hypertension	2.09e-05	0.000181	CcSEcCtD
Apomorphine—Headache—Lisinopril—hypertension	2.06e-05	0.000178	CcSEcCtD
Apomorphine—Nausea—Lisinopril—hypertension	1.95e-05	0.000169	CcSEcCtD
Apomorphine—ADRA2A—Metabolism—NOS3—hypertension	6.68e-07	6.93e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EP300—hypertension	6.66e-07	6.92e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RELA—hypertension	6.65e-07	6.91e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MMP9—hypertension	6.63e-07	6.88e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—hypertension	6.61e-07	6.86e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CDKN1A—hypertension	6.6e-07	6.86e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PTEN—hypertension	6.59e-07	6.84e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MTOR—hypertension	6.56e-07	6.81e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PTEN—hypertension	6.56e-07	6.81e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MMP9—hypertension	6.54e-07	6.79e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MMP9—hypertension	6.54e-07	6.79e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SERPINE1—hypertension	6.53e-07	6.78e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL8—hypertension	6.53e-07	6.78e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MTOR—hypertension	6.52e-07	6.77e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CDKN1A—hypertension	6.52e-07	6.76e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CDKN1A—hypertension	6.52e-07	6.76e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PTEN—hypertension	6.5e-07	6.75e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PTEN—hypertension	6.5e-07	6.75e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—SRC—hypertension	6.48e-07	6.73e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RELA—hypertension	6.47e-07	6.72e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MAPK8—hypertension	6.44e-07	6.69e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—AKT1—hypertension	6.43e-07	6.67e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SERPINE1—hypertension	6.43e-07	6.67e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—POMC—hypertension	6.4e-07	6.65e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RELA—hypertension	6.37e-07	6.61e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—INS—hypertension	6.37e-07	6.61e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MAPK8—hypertension	6.36e-07	6.6e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MAPK8—hypertension	6.36e-07	6.6e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MTOR—hypertension	6.34e-07	6.59e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—AKT1—hypertension	6.34e-07	6.58e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—AKT1—hypertension	6.34e-07	6.58e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—FGF2—hypertension	6.32e-07	6.57e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—hypertension	6.31e-07	6.55e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—hypertension	6.31e-07	6.55e-06	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—AKT1—hypertension	6.3e-07	6.55e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RHOA—hypertension	6.3e-07	6.54e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL8—hypertension	6.3e-07	6.54e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TGFB1—hypertension	6.3e-07	6.54e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EP300—hypertension	6.28e-07	6.52e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL8—hypertension	6.27e-07	6.51e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL2—hypertension	6.26e-07	6.5e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—EP300—hypertension	6.25e-07	6.49e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MTOR—hypertension	6.24e-07	6.48e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3R1—hypertension	6.24e-07	6.47e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—NOS3—hypertension	6.24e-07	6.47e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—FGF2—hypertension	6.22e-07	6.46e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—hypertension	6.21e-07	6.44e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RHOA—hypertension	6.2e-07	6.44e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EP300—hypertension	6.2e-07	6.44e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EP300—hypertension	6.2e-07	6.44e-06	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—hypertension	6.19e-07	6.43e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—hypertension	6.18e-07	6.42e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—hypertension	6.17e-07	6.41e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TGFB1—hypertension	6.17e-07	6.4e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IGF1—hypertension	6.16e-07	6.39e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT2—hypertension	6.15e-07	6.39e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3R1—hypertension	6.14e-07	6.37e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—NOS3—hypertension	6.14e-07	6.37e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—hypertension	6.13e-07	6.36e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—SRC—hypertension	6.11e-07	6.34e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTGS2—hypertension	6.11e-07	6.34e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL8—hypertension	6.1e-07	6.33e-06	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—AKT1—hypertension	6.09e-07	6.32e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—hypertension	6.08e-07	6.31e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TGFB1—hypertension	6.07e-07	6.3e-06	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—AKT1—hypertension	6.05e-07	6.29e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—hypertension	6.04e-07	6.28e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—SRC—hypertension	6.03e-07	6.26e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—SRC—hypertension	6.03e-07	6.26e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL8—hypertension	6e-07	6.23e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—hypertension	5.99e-07	6.22e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—hypertension	5.96e-07	6.19e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—hypertension	5.95e-07	6.18e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—hypertension	5.95e-07	6.18e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MMP9—hypertension	5.9e-07	6.13e-06	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—AKT1—hypertension	5.89e-07	6.11e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CDKN1A—hypertension	5.88e-07	6.11e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—hypertension	5.87e-07	6.1e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—hypertension	5.87e-07	6.1e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RELA—hypertension	5.87e-07	6.09e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PTEN—hypertension	5.87e-07	6.09e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	5.85e-07	6.07e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—hypertension	5.81e-07	6.03e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—hypertension	5.8e-07	6.02e-06	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	5.8e-07	6.02e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TGFB1—hypertension	5.79e-07	6.01e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RELA—hypertension	5.78e-07	6e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MTOR—hypertension	5.76e-07	5.98e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MAPK8—hypertension	5.74e-07	5.96e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—AKT1—hypertension	5.73e-07	5.94e-06	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—AKT1—hypertension	5.71e-07	5.93e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—hypertension	5.71e-07	5.92e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MMP9—hypertension	5.7e-07	5.92e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—hypertension	5.68e-07	5.9e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CDKN1A—hypertension	5.68e-07	5.9e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MMP9—hypertension	5.67e-07	5.89e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PTEN—hypertension	5.67e-07	5.88e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MTOR—hypertension	5.66e-07	5.88e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—FGF2—hypertension	5.66e-07	5.88e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CDKN1A—hypertension	5.65e-07	5.87e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RHOA—hypertension	5.64e-07	5.86e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PTEN—hypertension	5.64e-07	5.85e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EP300—hypertension	5.6e-07	5.81e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	5.58e-07	5.8e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOS3—hypertension	5.58e-07	5.8e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MAPK8—hypertension	5.54e-07	5.75e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL8—hypertension	5.53e-07	5.74e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—AKT1—hypertension	5.53e-07	5.74e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MMP9—hypertension	5.51e-07	5.73e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MAPK8—hypertension	5.51e-07	5.72e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—AKT1—hypertension	5.5e-07	5.71e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CDKN1A—hypertension	5.49e-07	5.7e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PTEN—hypertension	5.48e-07	5.69e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—hypertension	5.47e-07	5.68e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TGFB1—hypertension	5.46e-07	5.67e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL8—hypertension	5.44e-07	5.65e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SRC—hypertension	5.44e-07	5.65e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MMP9—hypertension	5.43e-07	5.63e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	5.41e-07	5.61e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EP300—hypertension	5.4e-07	5.61e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—hypertension	5.4e-07	5.61e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—hypertension	5.4e-07	5.61e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PTEN—hypertension	5.4e-07	5.6e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TGFB1—hypertension	5.39e-07	5.6e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TGFB1—hypertension	5.39e-07	5.6e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EP300—hypertension	5.38e-07	5.58e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MAPK8—hypertension	5.36e-07	5.57e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—hypertension	5.36e-07	5.56e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—AKT1—hypertension	5.35e-07	5.55e-06	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—AKT1—hypertension	5.34e-07	5.55e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PTEN—hypertension	5.33e-07	5.53e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—hypertension	5.3e-07	5.5e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—hypertension	5.28e-07	5.49e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—hypertension	5.28e-07	5.49e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MAPK8—hypertension	5.28e-07	5.48e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—AKT1—hypertension	5.26e-07	5.46e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—hypertension	5.26e-07	5.46e-06	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—AKT1—hypertension	5.26e-07	5.46e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RELA—hypertension	5.25e-07	5.46e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SRC—hypertension	5.25e-07	5.45e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EP300—hypertension	5.23e-07	5.43e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SRC—hypertension	5.23e-07	5.43e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—hypertension	5.18e-07	5.38e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—hypertension	5.18e-07	5.37e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MTOR—hypertension	5.15e-07	5.35e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EP300—hypertension	5.15e-07	5.34e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—hypertension	5.12e-07	5.31e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—hypertension	5.09e-07	5.29e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SRC—hypertension	5.08e-07	5.28e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—EP300—hypertension	5.08e-07	5.27e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—hypertension	5.08e-07	5.27e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SRC—hypertension	5e-07	5.19e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MMP9—hypertension	5e-07	5.19e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—hypertension	4.99e-07	5.19e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CDKN1A—hypertension	4.99e-07	5.18e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PTEN—hypertension	4.97e-07	5.16e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.95e-07	5.14e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—hypertension	4.95e-07	5.14e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MMP9—hypertension	4.92e-07	5.11e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CDKN1A—hypertension	4.91e-07	5.09e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PTEN—hypertension	4.89e-07	5.08e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—hypertension	4.88e-07	5.06e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—hypertension	4.87e-07	5.06e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MAPK8—hypertension	4.87e-07	5.05e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TGFB1—hypertension	4.87e-07	5.05e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—AKT1—hypertension	4.85e-07	5.04e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MAPK8—hypertension	4.79e-07	4.97e-06	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.78e-07	4.97e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—AKT1—hypertension	4.77e-07	4.96e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—hypertension	4.77e-07	4.95e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—hypertension	4.77e-07	4.95e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—hypertension	4.74e-07	4.93e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EP300—hypertension	4.74e-07	4.93e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—hypertension	4.71e-07	4.89e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—hypertension	4.71e-07	4.89e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TGFB1—hypertension	4.7e-07	4.88e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—hypertension	4.68e-07	4.86e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TGFB1—hypertension	4.67e-07	4.85e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EP300—hypertension	4.67e-07	4.85e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—hypertension	4.65e-07	4.82e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SRC—hypertension	4.61e-07	4.79e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—hypertension	4.6e-07	4.78e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—hypertension	4.58e-07	4.76e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—hypertension	4.57e-07	4.75e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—hypertension	4.56e-07	4.73e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TGFB1—hypertension	4.54e-07	4.72e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SRC—hypertension	4.54e-07	4.71e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—hypertension	4.5e-07	4.67e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—hypertension	4.49e-07	4.66e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—hypertension	4.48e-07	4.66e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MMP9—hypertension	4.48e-07	4.65e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TGFB1—hypertension	4.47e-07	4.64e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	4.46e-07	4.63e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—hypertension	4.46e-07	4.63e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PTEN—hypertension	4.45e-07	4.62e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—hypertension	4.44e-07	4.61e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—hypertension	4.44e-07	4.61e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—hypertension	4.42e-07	4.59e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—hypertension	4.39e-07	4.55e-06	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—AKT1—hypertension	4.38e-07	4.54e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—hypertension	4.36e-07	4.53e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MAPK8—hypertension	4.36e-07	4.52e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—AKT1—hypertension	4.34e-07	4.51e-06	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—AKT1—hypertension	4.29e-07	4.45e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EP300—hypertension	4.25e-07	4.41e-06	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—AKT1—hypertension	4.22e-07	4.38e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—hypertension	4.13e-07	4.29e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SRC—hypertension	4.13e-07	4.29e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TGFB1—hypertension	4.12e-07	4.28e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—hypertension	4.12e-07	4.27e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—hypertension	4.07e-07	4.22e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—hypertension	4.06e-07	4.22e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—hypertension	4.06e-07	4.22e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TGFB1—hypertension	4.06e-07	4.21e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—hypertension	4.04e-07	4.2e-06	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—AKT1—hypertension	4.03e-07	4.18e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—hypertension	4.02e-07	4.18e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—hypertension	4.01e-07	4.16e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—hypertension	3.98e-07	4.13e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—hypertension	3.87e-07	4.01e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—hypertension	3.85e-07	3.99e-06	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—AKT1—hypertension	3.8e-07	3.94e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—AKT1—hypertension	3.78e-07	3.92e-06	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—AKT1—hypertension	3.75e-07	3.89e-06	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—AKT1—hypertension	3.75e-07	3.89e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—hypertension	3.74e-07	3.88e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—hypertension	3.7e-07	3.84e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.69e-07	3.83e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—hypertension	3.68e-07	3.82e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—hypertension	3.67e-07	3.81e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—hypertension	3.62e-07	3.76e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—hypertension	3.54e-07	3.67e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—hypertension	3.52e-07	3.66e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—hypertension	3.42e-07	3.56e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—hypertension	3.39e-07	3.52e-06	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—AKT1—hypertension	3.38e-07	3.51e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—hypertension	3.37e-07	3.5e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—hypertension	3.34e-07	3.47e-06	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—AKT1—hypertension	3.26e-07	3.39e-06	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—AKT1—hypertension	3.25e-07	3.37e-06	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—AKT1—hypertension	3.16e-07	3.28e-06	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—AKT1—hypertension	3.11e-07	3.23e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—hypertension	3.11e-07	3.23e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—AKT1—hypertension	3.07e-07	3.19e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—hypertension	3.06e-07	3.17e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—hypertension	3.04e-07	3.16e-06	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—AKT1—hypertension	2.87e-07	2.98e-06	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—AKT1—hypertension	2.82e-07	2.93e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—hypertension	2.78e-07	2.89e-06	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—AKT1—hypertension	2.57e-07	2.66e-06	CbGpPWpGaD
